Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Change in Receivables (2020 - 2026)

Insight Molecular Diagnostics' Change in Receivables history spans 6 years, with the latest figure at $870000.0 for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 38.03% to $870000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$485000.0, a 142.96% decrease, with the full-year FY2025 number at -$485000.0, down 142.96% from a year prior.
  • Change in Receivables hit $870000.0 in Q4 2025 for Insight Molecular Diagnostics, up from -$254000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for IMDX hit a ceiling of $1.9 million in Q1 2025 and a floor of -$3.0 million in Q2 2025.
  • Historically, Change in Receivables has averaged $116950.0 across 5 years, with a median of $73000.0 in 2022.
  • Biggest five-year swings in Change in Receivables: surged 6585.71% in 2024 and later tumbled 3884.21% in 2025.
  • Tracing IMDX's Change in Receivables over 5 years: stood at $405000.0 in 2021, then crashed by 94.57% to $22000.0 in 2022, then dropped by 4.55% to $21000.0 in 2023, then surged by 6585.71% to $1.4 million in 2024, then plummeted by 38.03% to $870000.0 in 2025.
  • Business Quant data shows Change in Receivables for IMDX at $870000.0 in Q4 2025, -$254000.0 in Q3 2025, and -$3.0 million in Q2 2025.